定量磁敏感图评估胶质瘤的综合研究
结果显示,瘤内磁敏感信号(ITSS)异质性与高级别胶质瘤相关(p=0.006,AUC=0.72,敏感度70%,特异度73%),且与出血、坏死、弥散受限及明显强化相关;肿瘤实质低磁敏感有助于识别IDH突变型少突胶质细胞瘤(AUC=0.78,特异度100%)。QSM在评估IDH突变状态方面价值有限。
要点
- ITSS异质性提示高级别胶质瘤可能,需结合常规序列综合判断。
- 肿瘤实质相对低磁敏感有助于识别IDH突变型少突胶质细胞瘤。
- QSM对胶质瘤分级及IDH突变状态评估价值有限,不宜单独使用。
关键影像表现/征象
- ITSS形态学异质性的胶质瘤更类似高级别胶质瘤(p=0.006,AUC=0.72,敏感度70%,特异度73%)。
- 异质性ITSS与肿瘤出血、坏死、弥散受限及明显强化显著相关,且增强前后QSM无变化。
- 肿瘤实质相对低磁敏感有助于识别IDH突变型中的少突胶质细胞瘤(AUC=0.78,特异度100%)。
- 肿瘤实质相对高磁敏感在增强后显著升高(p=0.039)。
- 肿瘤实质磁敏感与ADC(r=0.61)及Cho/NAA(r=0.40)显著相关。
诊断标准与关键数值
- ITSS异质性预测高级别胶质瘤:AUC 0.72,敏感度70%,特异度73%(p=0.006)。
- 肿瘤实质相对低磁敏感识别IDH突变型少突胶质细胞瘤:AUC=0.78,特异度100%。
- 肿瘤实质磁敏感与ADC相关系数r=0.61,与Cho/NAA相关系数r=0.40。
临床应用与阅片要点
- 阅片时注意观察ITSS形态,异质性提示高级别可能,但需结合增强、DWI等序列。
- 增强前后QSM的ITSS不变,无需因增强而重复解读QSM的ITSS。
- 肿瘤实质低磁敏感可辅助提示少突胶质细胞瘤,但需结合IDH状态。
- QSM定量值不宜单独用于胶质瘤分级或IDH突变判断。
局限性
- 仅5例有增强前后配对QSM。
- 单中心设计,结果需外部验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: To comprehensively evaluate the glioma using quantitative susceptibility mapping (QSM).
MATERIALS AND METHODS: Forty-two patients (18 women; mean age, 45 years) with pathologically confirmed gliomas were retrospectively included. All the patients underwent conventional and advanced MRI examinations (QSM, DWI, MRS, etc.). Five patients underwent paired QSM (pre- and post-enhancement). Four Visually Accessible Rembrandt Image (VASARI) features and intratumoural susceptibility signal (ITSS) were observed. Three ROIs each were manually drawn separately in the tumour parenchyma with relatively high and low magnetic susceptibility. The association between the tumour's magnetic susceptibility and other MRI parameters was also analysed.
RESULTS: Morphologically, gliomas with heterogeneous ITSS were more similar to high-grade gliomas (p = 0.006, AUC: 0.72, sensitivity: 70%, and specificity: 73%). Heterogeneous ITSS was significantly associated with tumour haemorrhage, necrosis, diffusion restriction, and avid enhancement but did not change between pre- and post-enhanced QSM. Quantitatively, tumour parenchyma magnetic susceptibility had limited value in grading gliomas and identifying IDH mutation status, whereas the relatively low magnetic susceptibility of the tumour parenchyma helped identify oligodendrogliomas in IDH mutated gliomas (AUC = 0.78) with high specificity (100%). The relatively high tumour magnetic susceptibility significantly increased after enhancement (p = 0.039). Additionally, we found that the magnetic susceptibility of the tumour parenchyma was significantly correlated with ADC (r = 0.61) and Cho/NAA (r = 0.40).
CONCLUSIONS: QSM is a promising candidate for the comprehensive evaluation of gliomas, except for IDH mutation status. The magnetic susceptibility of tumour parenchyma may be affected by tumour cell proliferation.
KEY POINTS: • Morphologically, gliomas with a heterogeneous intratumoural susceptibility signal (ITSS) are more similar to high-grade gliomas (p = 0.006; AUC, 0.72; sensitivity, 70%; and specificity, 73%). Heterogeneous ITSS was significantly associated with tumour haemorrhage, necrosis, diffusion restriction, and avid enhancement but did not change between pre- and post-enhanced QSM. • Tumour parenchyma's relatively low magnetic susceptibility helped identify oligodendroglioma with high specificity. • Tumour parenchyma magnetic susceptibility was significantly correlated with ADC (r = 0.61) and Cho/NAA (r = 0.40).
引用
- Zeng, Ma, Xie, et al. Quantitative susceptibility mapping evaluation of glioma. Eur Radiol. 2023. PMID: 37095360. doi:10.1007/s00330-023-09647-4
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。